AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹31,724 Cr | ₹29,002 Cr | ₹24,855 Cr | ₹23,455 Cr | ₹24,775 Cr |
What is the latest Revenue of AUROBINDO PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹31,724 Cr |
| Mar2024 | ₹29,002 Cr |
| Mar2023 | ₹24,855 Cr |
| Mar2022 | ₹23,455 Cr |
| Mar2021 | ₹24,775 Cr |
How is Revenue of AUROBINDO PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹31,724 Cr | 9.39 | |
| Mar2024 | ₹29,002 Cr | 16.68 | |
| Mar2023 | ₹24,855 Cr | 5.97 | |
| Mar2022 | ₹23,455 Cr | -5.32 | |
| Mar2021 | ₹24,775 Cr | - | |
Compare Revenue of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹74,772.2 Cr | -1.3% | 12.1% | 17.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,825.0 Cr | -1.6% | 5.7% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,535.0 Cr | -4.2% | -1.4% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,733.0 Cr | -2.8% | 5.7% | 39.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,094.0 Cr | -3.2% | 1.2% | 14.2% | Stock Analytics | |
| CIPLA | ₹103,513.0 Cr | -3.6% | -3.7% | -10.2% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -1.3% |
12.1% |
17.3% |
| SENSEX | -2.7% |
-9.1% |
2.6% |
You may also like the below Video Courses